Charles A Enke Selected Research

B72.3 antibody

9/2005	Effect of platelet-derived growth factor receptor-beta inhibition with STI571 on radioimmunotherapy.
7/2002	Potentiation of radioimmunotherapy with response-selective peptide agonist of human C5a.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Charles A Enke Research Topics

Disease

14	Neoplasms (Cancer) 12/2021 - 07/2002
8	Prostatic Neoplasms (Prostate Cancer) 01/2021 - 01/2006
6	Pancreatic Neoplasms (Pancreatic Cancer) 12/2021 - 01/2007
2	Carcinogenesis 12/2021 - 10/2019
2	Lymphoma (Lymphomas) 01/2019 - 02/2005
2	Adenocarcinoma 09/2005 - 07/2002
1	Arthrogryposis renal dysfunction cholestasis syndrome 04/2017
1	Ascites 02/2014
1	Brain Diseases (Brain Disorder) 02/2014
1	Hepatic Veno-Occlusive Disease (Disease, Hepatic Veno-Occlusive) 02/2014
1	Liver Diseases (Liver Disease) 02/2014
1	Radiation Injuries (Radiation Sickness) 02/2014
1	Liver Failure 02/2014
1	Neoplasm Metastasis (Metastasis) 12/2013
1	Rhabdomyosarcoma 04/2012
1	Colorectal Neoplasms (Colorectal Cancer) 05/2011
1	Rectal Neoplasms (Rectal Cancer) 10/2010
1	Hematologic Neoplasms (Hematological Malignancy) 09/2005
1	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 02/2005
1	Acute Liver Failure (Fulminant Hepatic Failure) 09/2003

Drug/Important Bio-Agent (IBA)

3	AndrogensIBA 01/2019 - 09/2012
3	Peptides (Polypeptides)IBA 01/2013 - 07/2002
3	Imatinib Mesylate (Gleevec)FDA Link 05/2011 - 09/2005
2	GTP Phosphohydrolases (GTPases)IBA 01/2020 - 11/2014
2	RadiopharmaceuticalsIBA 01/2015 - 12/2013
2	AlbuminsIBA 02/2014 - 01/2013
2	VaccinesIBA 01/2013 - 02/2005
2	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 01/2007 - 09/2005
2	Monoclonal AntibodiesIBA 09/2005 - 07/2002
2	B72.3 antibodyIBA 09/2005 - 07/2002
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 12/2021
1	Proteins (Proteins, Gene)FDA Link 12/2021
1	Messenger RNA (mRNA)IBA 12/2021
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 12/2021
1	Metformin (Glucophage)FDA LinkGeneric 01/2021
1	Oncogene Proteins (Oncogene Protein)IBA 10/2019
1	Biological ProductsIBA 10/2019
1	Long-Acting Thyroid Stimulator (LATS)IBA 10/2019
1	HoloenzymesIBA 10/2019
1	Phosphates (Orthophosphate)IBA 01/2015
1	Androgen Receptors (Androgen Receptor)IBA 01/2015
1	Indicators and Reagents (Reagents)IBA 01/2015
1	Radioisotopes (Radionuclides)IBA 01/2015
1	BilirubinIBA 02/2014
1	Alkaline PhosphataseIBA 02/2014
1	AsialoglycoproteinsIBA 02/2014
1	Glucose (Dextrose)FDA LinkGeneric 02/2014
1	Radium-223IBA 12/2013
1	AutoantigensIBA 01/2013
1	Immunoglobulin G (IgG)IBA 01/2013
1	EpitopesIBA 01/2013
1	sipuleucel-T (APC8015)FDA Link 09/2012
1	Abiraterone AcetateIBA 09/2012
1	Docetaxel (Taxotere)FDA Link 09/2012
1	Platelet-Derived Growth Factor beta Receptor (Receptor, Platelet Derived Growth Factor beta)IBA 09/2005
1	Proteasome InhibitorsIBA 02/2005
1	AnaphylatoxinsIBA 01/2004

Therapy/Procedure

13	Radiotherapy 01/2021 - 01/2005
12	Therapeutics 01/2019 - 02/2005
5	Radioimmunotherapy 05/2011 - 07/2002
3	Drug Therapy (Chemotherapy) 01/2019 - 02/2005
2	Immunotherapy 01/2019 - 01/2013
2	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 04/2017 - 04/2012
2	Castration 01/2016 - 09/2012
2	Transplantation 02/2014 - 09/2003
2	Aftercare (After-Treatment) 05/2011 - 02/2005
1	Prostatectomy (Retropubic Prostatectomy) 01/2021
1	Combined Modality Therapy 01/2019
1	Salvage Therapy 01/2019
1	Parenteral Nutrition 02/2014
1	Investigational Therapies (Experimental Therapy) 02/2014
1	Brachytherapy 09/2012
1	Conformal Radiotherapy 04/2012
1	X-Ray Therapy 01/2006
1	Liver Transplantation 09/2003